Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
B Zeng, L Gao, Q Zhou, K Yu, F Sun - BMC medicine, 2022 - Springer
Background It was urgent and necessary to synthesize the evidence for vaccine
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
WY Au, PPH Cheung - Bmj, 2022 - bmj.com
Objective To evaluate the effectiveness of heterologous and homologous covid-19 vaccine
regimens with and without boosting in preventing covid-19 related infection, hospital …
regimens with and without boosting in preventing covid-19 related infection, hospital …
[HTML][HTML] Covid-19: virology, variants, and vaccines
Abstract As of 25 January 2022, over 349 million individuals have received a confirmed
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
Effectiveness of E-Learning Learning to Improve Student Learning Outcomes at Madrasah Aliyah
E-learning is a new learning model carried out by the government to support student
learning activities during a pandemic. This study uses a quantitative approach. Given the …
learning activities during a pandemic. This study uses a quantitative approach. Given the …
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians
S Rakshit, S Babji, C Parthiban, R Madhavan, V Adiga… - npj Vaccines, 2023 - nature.com
Detailed characterisation of immune responses induced by COVID-19 vaccines rolled out in
India: COVISHIELDTM (CS) and COVAXIN®(CO) in a pre-exposed population is only …
India: COVISHIELDTM (CS) and COVAXIN®(CO) in a pre-exposed population is only …
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults
Due to waning immunity following primary immunization with COVID-19 vaccines, booster
doses may be required. The present study assessed a heterologous booster of SII-NVX …
doses may be required. The present study assessed a heterologous booster of SII-NVX …
Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries
The availability and use of vaccines for the coronavirus disease 2019 (COVID-19) in low and
middle-income countries (L/MICs) lags far behind more affluent countries, and vaccines …
middle-income countries (L/MICs) lags far behind more affluent countries, and vaccines …
[HTML][HTML] COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review
Abstract Introduction Health care workers (HCWs) have been at increased risk of infection
during the SARS-CoV-2 pandemic and as essential workers have been prioritised for …
during the SARS-CoV-2 pandemic and as essential workers have been prioritised for …
Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis
A Contractor, S Shivaprakash, A Tiwari, MS Setia… - PLoS …, 2022 - journals.plos.org
Background India started its vaccination programme for Coronavirus-19 infection (COVID-
19) on 16 January 2021 with CovishieldTM (Oxford/Astra Zeneca vaccine manufactured by …
19) on 16 January 2021 with CovishieldTM (Oxford/Astra Zeneca vaccine manufactured by …
Effect of hybrid immunity, school reopening, and the Omicron variant on the trajectory of the COVID-19 epidemic in India: a modelling study
Background The course of the COVID-19 pandemic has been driven by several dynamic
behavioral, immunological, and viral factors. We used mathematical modeling to explore …
behavioral, immunological, and viral factors. We used mathematical modeling to explore …